.jpg){kind=logo}
Share
Raymond W. Cohen
Resonant Link Medical has appointed Raymond W. Cohen as Chair of its Board of Directors, supporting the company’s growth and expansion of its Aurion WPT™ wireless technology platform across diverse clinical applications.
Cohen is a seasoned MedTech leader with extensive experience guiding companies through commercialization, IPOs, and acquisitions. Most recently, he served as CEO of Axonics, leading the company from its founding to a US$3.7 billion acquisition by Boston Scientific Corporation.
As Chair, Cohen will help advance Resonant Link Medical’s strategic initiatives, including team expansion, brand development, and broader adoption of the Aurion WPT™ wireless power and data transfer technology across implantable devices, ranging from ventricular assist devices and brain-computer interfaces to neurostimulators and diagnostic tools.
His appointment reinforces the company’s commitment to innovation, market growth, and leadership in wireless medical technologies.
